6-32038820-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000500.9(CYP21A2):c.292+9C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.708 in 1,378,688 control chromosomes in the GnomAD database, including 343,822 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.72 ( 38407 hom., cov: 28)
Exomes 𝑓: 0.71 ( 305415 hom. )
Consequence
CYP21A2
NM_000500.9 intron
NM_000500.9 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.82
Genes affected
CYP21A2 (HGNC:2600): (cytochrome P450 family 21 subfamily A member 2) This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and hydroxylates steroids at the 21 position. Its activity is required for the synthesis of steroid hormones including cortisol and aldosterone. Mutations in this gene cause congenital adrenal hyperplasia. A related pseudogene is located near this gene; gene conversion events involving the functional gene and the pseudogene are thought to account for many cases of steroid 21-hydroxylase deficiency. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BP6
Variant 6-32038820-C-T is Benign according to our data. Variant chr6-32038820-C-T is described in ClinVar as [Benign]. Clinvar id is 256289.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-32038820-C-T is described in Lovd as [Benign]. Variant chr6-32038820-C-T is described in Lovd as [Likely_benign].
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.781 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CYP21A2 | NM_000500.9 | c.292+9C>T | intron_variant | ENST00000644719.2 | NP_000491.4 | |||
CYP21A2 | NM_001128590.4 | c.202+196C>T | intron_variant | NP_001122062.3 | ||||
CYP21A2 | NM_001368143.2 | c.-133+9C>T | intron_variant | NP_001355072.1 | ||||
CYP21A2 | NM_001368144.2 | c.-133+196C>T | intron_variant | NP_001355073.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CYP21A2 | ENST00000644719.2 | c.292+9C>T | intron_variant | NM_000500.9 | ENSP00000496625 | P1 |
Frequencies
GnomAD3 genomes AF: 0.716 AC: 107500AN: 150210Hom.: 38353 Cov.: 28
GnomAD3 genomes
AF:
AC:
107500
AN:
150210
Hom.:
Cov.:
28
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.737 AC: 157800AN: 214146Hom.: 58091 AF XY: 0.733 AC XY: 84877AN XY: 115832
GnomAD3 exomes
AF:
AC:
157800
AN:
214146
Hom.:
AF XY:
AC XY:
84877
AN XY:
115832
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.707 AC: 868177AN: 1228364Hom.: 305415 Cov.: 20 AF XY: 0.708 AC XY: 437559AN XY: 618032
GnomAD4 exome
AF:
AC:
868177
AN:
1228364
Hom.:
Cov.:
20
AF XY:
AC XY:
437559
AN XY:
618032
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.716 AC: 107613AN: 150324Hom.: 38407 Cov.: 28 AF XY: 0.717 AC XY: 52661AN XY: 73464
GnomAD4 genome
AF:
AC:
107613
AN:
150324
Hom.:
Cov.:
28
AF XY:
AC XY:
52661
AN XY:
73464
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2592
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 30, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at